Breakthrough Alzheimer’s Drug Leqembi Gains Medicare Coverage: A Promising Step Forward
A step forward in Alzheimer’s treatment has emerged with the current approval of the drug Leqembi with the aid of the U.S. Food and Drug Administration (FDA). This novel medicinal drug gives hope to patients and their households by way of concentrating on the underlying reasons for the disorder. In a big improvement, Medicare has…
